Healthcare / Medical - Diagnostics & ResearchUpdated 2026-05-10 22:07 UTC

AIM/DXRX stock hub

AIM/DXRX has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

AIM/DXRXis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

149.4M

London Stock Exchange AIM

Market data

Live price

Current market quote for this ticker.

Current price

AIM/DXRX

In the news

Latest news · AIM/DXRX

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E284.7

P25 12.9P50 16.9P75 23.5

Trailing P/En/a

P25 15.9P50 22.9P75 35.8

ROE-4

P25 -54.2P50 2.1P75 13.7

ROIC-7.3

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All AIM/DXRX market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

201

Groups with data

Currency

GBP

Showing 201 of 201 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United Kingdom
Country code	UK
Employees	213
Employees Change	14%
Employees Change Percent	7.04
Enterprise value	GBX 140.2M
Exchange	London Stock Exchange AIM
Financial currency	GBP
First seen	2026-05-10
Industry	Medical - Diagnostics & Research
Isin	GB00BJQTGV64
Last refreshed	2026-05-10
Market cap	GBX 149.4M
Price	GBX 176
Price currency	GBX
Rev Per Employee	161,511.74x
Sector	Healthcare
Sic	8731
Symbol	aim/DXRX
Website	https://www.diaceutics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-1.02%
EV Earnings	-92.21x
EV/EBITDA	91.79x
EV/FCF	14,016.4x
EV/Sales	4.07x
FCF yield	0.01%
Forward P/E	284.68x
P/B ratio	4.01x
P/S ratio	4.34x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-5.96%
EBITDA Margin	3.85%
FCF margin	0.03%
Gross margin	86.12%
Gross Profit	GBX 29.6M
Gross Profit Growth	4.8%
Gross Profit Growth Q	12.64%
Gross Profit Growth3 Y	14.56%
Gross Profit Growth5 Y	12.09%
Net Income	GBX -1.5M
Net Income Growth Quarters	2%
Net Income Growth Years	1%
Pretax Margin	-4.82%
Profit Margin	-4.42%
Profit Per Employee	GBX -7,136
ROA	-2.85
Roa5y	-1.24
ROCE	-5.36
ROE	-4
Roe5y	-0.88
ROIC	-7.32
Roic5y	-3.66

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	46.71%
Cagr3y	21.96%
Cagr5y	7%
EPS Growth Quarters	2
EPS Growth Years	1
FCF Growth	-99.39%
FCF Growth Q	-49.59%
FCF Growth3 Y	-79.65%
FCF Growth5 Y	-71.04%
OCF Growth	-94.11%
OCF Growth Q	-47.48%
OCF Growth10 Y	-20.32%
OCF Growth3 Y	-57.03%
OCF Growth5 Y	-54.08%
Revenue Growth	31.83x
Revenue Growth Q	18.21x
Revenue Growth Quarters	9x
Revenue Growth Years	4x
Revenue Growth3 Y	13.23x
Revenue Growth5 Y	12.02x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	GBX 0.77
Assets	GBX 44.4M
Cash	GBX 10.4M
Current Assets	GBX 24.5M
Current Liabilities	GBX 6.2M
Debt	GBX 1.1M
Debt EBITDA	GBX 0.74
Debt Equity	GBX 0.03
Debt FCF	GBX 113
Equity	GBX 37.2M
Interest Coverage	-37.25
Liabilities	GBX 7.2M
Long Term Assets	GBX 20M
Long Term Liabilities	GBX 998,000
Net Cash	GBX 9.3M
Net Cash By Market Cap	GBX 6.19
Net Cash Growth	-40.76%
Net Debt EBITDA	GBX -6.98
Net Debt Equity	GBX -0.25
Net Debt FCF	GBX -925
Tangible Book Value	GBX 21.9M
Tangible Book Value Per Share	GBX 0.26
WACC	9.27

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.96
Net Working Capital	GBX 8.1M
Quick ratio	3.66
Working Capital	GBX 18.3M
Working Capital Turnover	GBX 1.72

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.19%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	46.67%
200-day SMA	152.3
3Y total return	81.44%
50-day SMA	156.8
50-day SMA vs 200-day SMA	50over200
5Y total return	40.24%
All Time High	195
All Time High Change	-9.74%
All Time High Date	2020-07-29
All Time Low	74
All Time Low Change	137.84%
All Time Low Date	2023-01-04
ATR	5.12
Beta	0.92
Beta1y	0.28
Beta2y	0.45
Ch YTD	37.5
High	177.3
High52	180
High52 Date	2026-05-07
High52ch	-2.22%
Low	176
Low52	112.3
Low52 Date	2025-06-24
Low52ch	56.79%
Ma50ch	12.28%
Price vs 200-day SMA	15.59%
RSI	68.94
RSI Monthly	60.35
RSI Weekly	62.8
Sharpe ratio	1.2x
Sortino ratio	2.27
Total Return	-0.19%
Tr YTD	37.5
Tr1m	8.98%
Tr1w	6.34%
Tr3m	6.02%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	GBX -2M
Operating margin	-5.96

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	48,658,734%
Net Borrowing	-242,000
Shares Insiders	23.21%
Shares Institutions	47.95%
Shares Out	84,653,826
Shares Qo Q	0.1%
Shares Yo Y	0.19%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	GBX -1M
Average Volume	229,301.6x
Bv Per Share	0.44
CAPEX	GBX -94,000
Ch1m	8.98
Ch1w	6.34
Ch1y	46.67
Ch3m	6.02
Ch3y	81.44
Ch5y	40.24
Ch6m	7.32
Change	-0.28%
Change From Open	-0.28
Close	176.5
Days Gap	0
Depreciation Amortization	3,375,000
Dollar Volume	2,238,544
Earnings Date	2026-05-27
EBIT	GBX -2M
EBITDA	GBX 1.3M
EPS	GBX -0.02
F Score	4
FCF	GBX 10,000
FCF EV Yield	0.01x
FCF Per Share	GBX 0
Financing CF	-242,000
Fiscal Year End	December
Founded	2,005
Income Tax	GBX -137,000
Investing CF	-5,561,000
Is Primary Listing	1
Last Earnings Date	2025-12-24
Last Report Date	2025-06-30
Ma150	155.4
Ma150ch	13.23%
Ma20	169.1
Ma20ch	4.07%
Net CF	-6,365,000
Next Earnings Date	2026-05-27
Open	176.5
P FCF Ratio	14,941.4
P OCF Ratio	1,436.7
Position In Range	0
Ppne	1,711,000
Price Date	2026-05-08
Price EBITDA	GBX 113
Ptbv Ratio	6.83
Relative Volume	0.06x
Revenue	34,402,000x
SBC By Revenue	3.01x
Share Based Comp	1,035,000
Tax By Revenue	-0.4x
Tr6m	7.32%
Volume	12,719
Z Score	11.4

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does AIM/DXRX pay a dividend?

Capital-return profile for this ticker.

Performance

AIM/DXRX stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns AIM/DXRX?

Insider, institutional, and short-interest positioning.

Institutional ownership

+47.9%

Share of float held by funds and institutions

Insider ownership

+23.2%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.2%

Negative means the company is buying back shares.

Technical

AIM/DXRX momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

68.9

Neutral momentum band

Price vs 200-day MA

+15.6%

50/200-day relationship not available

Beta (5Y)

0.92

Moves roughly with the market

Sharpe ratio

1.20

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About AIM/DXRX

Hub-level FAQ points readers to the deeper analysis pages.

What is the current aim/DXRX stock rating?

aim/DXRX is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full aim/DXRX analysis?

The full report lives at /stocks/aim/DXRX/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for aim/DXRX?

The latest report frames aim/DXRX around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the aim/DXRX page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.